91AV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information

Meet the Editor Online: RSC Medicinal 91AV

2 November 2020 16:00-17:30, India


Introduction
Covid-19 has brought about an unprecedented situation across globe and the impact of it on the research landscape is going to be paramount. While we all stay isolated at our homes, it is also essential for us to stay connected with the community.
 
RSC Meet the Editor Webinars provide researchers with a platform to interact and engage with the journal editors and international board members while you stay safe at your homes.
 
The webinar provides researchers an opportunity to hear some of the exciting research by leading scientists on our journal board. You will also have the opportunity to interact with them and clarify your burning questions on the key aspects of their research.
 
Join us to make the best use of this time and be a part of the interactive discussions. You could gain meaningful insights from journal editors on scholarly publishing, peer review, ethics and plagiarism helping you to advance your career.
 
The webinars are free to attend and would not only be beneficial to students and researchers pursuing chemical science but also for anybody wanting to develop their skills at any stage of their research career.

Join Dr Venkata Palle, Senior Vice President of Discovery Research, Lupin Pharma,

Prof Jayanta Haldar, Associate Professor, Jawahar Lal Nehru Centre for Advanced Scientific Research (JNCASR), and

Dr. Katie Lim, Executive Editor, RSC Medicinal 91AV.
Online webinar featuring key scientific and publishing insights.

Programme
Scientific Talk  1:  16:00 - 16:20 mins
Dr Venkata Palle
Exploiting Specific Amino Acid Residues of PARP as Targets for the Design of a Novel PARP Inhibitor


Publishing Talk : 16:20 - 16:30 mins
Dr. Katie Lim
Meet the Editor: RSC Medicinal 91AV


Scientific Talk  2 : 16:30 - 16:50 mins
Dr Jayanta Haldar
Tackling emergent infections: A chemical perspective to drug design and development

Q&A : 16:50 - 17:30 mins
Speakers
Dr Jayanta Haldar, Jawaharlal Nehru Centre for Advanced Scientific Research , India

Dr. Jayanta Haldar is an Associate Professor at New 91AV Unit, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bangalore, India. He is also associated with the School of Advanced Materials (SAMat). Prof Haldar did his masters & PhD from IISc Bangalore and Postdoc from Massachusetts Institute of Technology, USA. His research interests are towards the development of molecular strategies for the prevention and treatment of infectious diseases. He has published many international peer-reviewed papers, book chapters and review articles and has also got many patents in his name.

His research work also has been featured in leading print and television media. He has been awarded as a Ramanujan Fellow from the Department of Science and Technology, Government of India, in 2010. Inventions from his lab received two Biotechnology Industry Research Assistance Council (BIRAC-GYTI) awards in 2015 and 2016 and received two Gandhian Young Technological Innovation appreciation awards in 2015 and 2016. He is an editorial board member of the journals “Microbial Pathogenesis” and “RSC Medicinal 91AV” He also serves as an Editorial Advisory Board Members of journals such as Biomacromolecules and ACS Infectious Diseases. He has been awarded CDRI-Awards 2017 for Excellence in Drug Research and received Chemical Research Society of India (CRSI) Bronze Medal 2017 and Sheik Saqr Career Award Fellowship in 2018. Dr. Haldar has also been awarded for Indo-US virtual Newtworks for Covid-19 program by Indo-US Science and Technology Forum in 2020. 


Dr. Katie Lim, Executive Editor
91AV , United Kingdom

Katie obtained her undergraduate Masters degree and PhD from the University of Bristol, UK. Currently based in Cambridge, she has over six years of experience at the 91AV working on a variety of different journals, including as Executive Editor of the physical chemistry and sustainability journal portfolio and Managing Editor of RSC Advances.
As Executive Editor of the organic chemistry journal portfolio at the 91AV, Katie leads 4 RSC titles: OBC, Molecular Omics, RSC Medicinal 91AV and Natural Product Reports (NPR). 


Dr Venkata Palle, Senior Vice President of Discovery Research
Lupin Pharma, India

Dr. Venkata Palle is currently Senior Vice President of Discovery Research at Lupin Pharma. Prior to joining Lupin, Dr. Palle played a leading role in Medicinal 91AV in the drug discovery efforts at Advinus Therapeutics (Pune, India), Ranbaxy Laboratories (Gurgoan, India), CV Therapeutics (Now Gilead Sciences, Palo Alto, CA, USA) and NeXstar Pharmaceuticals (Boulder, CO, USA). He is co-inventor of currently marketed drug Regadenoson (LexiScan). He has also developed a number of drug candidates that are in various stages of clinical development. Dr.Palle has more than hundred granted US patents and over fifty publications to his credit. He received Ph.D. in Organic 91AV from Indian Institute of Science (Bangalore) and conducted post-doctoral work at the University of Rhode Island (Kingston, Rhode Island, USA)



Venue

Go To Webinar, India

Organised by
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*